<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02378285</url>
  </required_header>
  <id_info>
    <org_study_id>ArthrexFR-001</org_study_id>
    <secondary_id>2009-A00804-53</secondary_id>
    <nct_id>NCT02378285</nct_id>
  </id_info>
  <brief_title>Treatment of Epicondylitis by Ultrasound-guided Local Injections of PRP (Platelet Rich Plasma)</brief_title>
  <official_title>Treatment of Epicondylitis by Ultrasound-guided Local Injections of Autologous Conditioned Plasma (ACP®): a Double-blind Placebo-controlled Randomized Clinical Trial With One-year Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arthrex SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arthrex SAS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess efficacy of two intra-tendinous injections of
      platelet-rich plasma (PRP) on epicondylitis of recent evolution (≤ 3 months) compared
      compared to two intra-tendinous injections of saline solution (placebo).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a prospective double-blind placebo-controlled randomized trial. Two
      ultrasound-guided injections of either PRP (ACP®, Arthrex) or saline solution were performed
      at 4 weeks interval.

      Exclusion criterion was previous corticosteroid infiltration. All infiltrations were
      performed by Dr Bernard Montalvan. The selection of patients and the evaluation were
      conducted by Dr Patrick Le Goux who did not know which treatment had been allocated to which
      patient.

      In the facility, no one apart from the investigators had access to full patient data.

      An independent company represented by Mrs Amandine Ramseyer was hired to design, follow and
      carry the statistical analysis of the study. The data she got from the investigators were
      anonymous.

      Patients were monitored by an independent evaluator blinded to treatment at baseline and 1,
      3, 6 and 12 months follow-up.

      Secondary criteria were the Roles-Maudsley score and the assessment of pain on isometric
      contraction of the extensor carpi radialis brevis and of the extensor digitorum communis.

      The main evaluation criterion was the relative improvement from baseline to 6 months in pain
      score on visual analog scale (0-10).

      Intragroup and intergroup intention-to-treat analyses were performed using Student's t-tests,
      applying the last-observation carried forward method. Differences of proportions were tested
      using chi-square. The sample size calculated was 22 patients per group so that this study had
      a power of 90% with typeI error rate α=0.05 to demonstrate a significant greater improvement
      of the global pain score of at least 10%, in the PRP over the placebo group with a standard
      deviation of 0.10. A &quot;p&quot; value of less than 0.05 was considered to be statistically
      significant. The SPSS software (version 19 for Windows) was used to perform statistics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global pain score</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Roles and Maudsley score</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain on ECRB* contraction</measure>
    <time_frame>1 year</time_frame>
    <description>% positive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain on EDC** contraction</measure>
    <time_frame>1 year</time_frame>
    <description>% positive</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Epicondylitis</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ACP infiltration: 2 mL at 0 and 4 weeks with ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline solution group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline solution infiltration: 2mL at 0 and 4 weeks with ultrasound guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACP</intervention_name>
    <description>ACP is prepared using the Autologous Conditioned Plasma (ACP®) device from Arthrex (Naples, Florida, USA), following the supplier instructions. 2 mL of ACP are transferred in a standard 2 mL injection syringe by a nurse. The standard 2 mL injection syringe is then given to the physician.The patient is installed on a table with his arm in supine position. A local subcutaneous anesthesia (2 ml of 1% lidocaine) is done just before the infiltration by the physician. The infiltration is then done guided by ultrasound.</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline solution</intervention_name>
    <description>2 mL of saline solution are placed in a standard injection syringe by a nurse. The syringe is then given to the physician. The patient is installed on a table with his arm in supine position. A local subcutaneous anesthesia (2 ml of 1% lidocaine) is done just before the infiltration by the physician. The infiltration is then done guided by ultrasound.</description>
    <arm_group_label>Saline solution group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from tennis elbow for less than three months

          -  Patients having never received former medical or orthopedic treatment for tennis elbow

        Exclusion Criteria:

          -  Patients having received any treatment for this specific pathology

          -  Evidence of ongoing tumoral affection (controlled by MRI)

          -  Tennis elbow history

          -  Elbow fracture history

          -  Associated elbow pathology

          -  Inflammatory rheumatic disorders

          -  Bleeding disorders

          -  Ongoing anticoagulation therapy

          -  Allergy to local anesthetic

          -  Ongoing or previous cancer affection

          -  Pregnancy

          -  Diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Hardy, Pr</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Ambroise Paré Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Ambroise Paré</name>
      <address>
        <city>Boulogne</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>De Smedt T, de Jong A, Van Leemput W, Lieven D, Van Glabbeek F. Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment. Br J Sports Med. 2007 Nov;41(11):816-9. Epub 2007 Jul 6. Review.</citation>
    <PMID>17616547</PMID>
  </reference>
  <reference>
    <citation>Nirschl RP. Elbow tendinosis/tennis elbow. Clin Sports Med. 1992 Oct;11(4):851-70. Review.</citation>
    <PMID>1423702</PMID>
  </reference>
  <reference>
    <citation>McCormack RR Jr, Inman RD, Wells A, Berntsen C, Imbus HR. Prevalence of tendinitis and related disorders of the upper extremity in a manufacturing workforce. J Rheumatol. 1990 Jul;17(7):958-64.</citation>
    <PMID>2213764</PMID>
  </reference>
  <reference>
    <citation>Ono Y, Nakamura R, Shimaoka M, Hiruta S, Hattori Y, Ichihara G, Kamijima M, Takeuchi Y. Epicondylitis among cooks in nursery schools. Occup Environ Med. 1998 Mar;55(3):172-9.</citation>
    <PMID>9624268</PMID>
  </reference>
  <reference>
    <citation>Shiri R, Viikari-Juntura E. Lateral and medial epicondylitis: role of occupational factors. Best Pract Res Clin Rheumatol. 2011 Feb;25(1):43-57. doi: 10.1016/j.berh.2011.01.013. Review.</citation>
    <PMID>21663849</PMID>
  </reference>
  <reference>
    <citation>Hamilton PG. The prevalence of humeral epicondylitis: a survey in general practice. J R Coll Gen Pract. 1986 Oct;36(291):464-5.</citation>
    <PMID>3440991</PMID>
  </reference>
  <reference>
    <citation>Murtagh JE. Tennis elbow. Aust Fam Physician. 1988 Feb;17(2):90-1, 94-5.</citation>
    <PMID>3358752</PMID>
  </reference>
  <reference>
    <citation>Smidt N, Lewis M, Hay EM, Van der Windt DA, Bouter LM, Croft P. A comparison of two primary care trials on tennis elbow: issues of external validity. Ann Rheum Dis. 2005 Oct;64(10):1406-9. Epub 2005 Mar 30.</citation>
    <PMID>15800009</PMID>
  </reference>
  <reference>
    <citation>Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006 Nov 4;333(7575):939. Epub 2006 Sep 29.</citation>
    <PMID>17012266</PMID>
  </reference>
  <reference>
    <citation>Lindenhovius A, Henket M, Gilligan BP, Lozano-Calderon S, Jupiter JB, Ring D. Injection of dexamethasone versus placebo for lateral elbow pain: a prospective, double-blind, randomized clinical trial. J Hand Surg Am. 2008 Jul-Aug;33(6):909-19. doi: 10.1016/j.jhsa.2008.02.004.</citation>
    <PMID>18656765</PMID>
  </reference>
  <reference>
    <citation>Newcomer KL, Laskowski ER, Idank DM, McLean TJ, Egan KS. Corticosteroid injection in early treatment of lateral epicondylitis. Clin J Sport Med. 2001 Oct;11(4):214-22.</citation>
    <PMID>11753057</PMID>
  </reference>
  <reference>
    <citation>Roukis TS, Zgonis T, Tiernan B. Autologous platelet-rich plasma for wound and osseous healing: a review of the literature and commercially available products. Adv Ther. 2006 Mar-Apr;23(2):218-37. Review.</citation>
    <PMID>16751155</PMID>
  </reference>
  <reference>
    <citation>Ranly DM, McMillan J, Keller T, Lohmann CH, Meunch T, Cochran DL, Schwartz Z, Boyan BD. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am. 2005 Sep;87(9):2052-64.</citation>
    <PMID>16140821</PMID>
  </reference>
  <reference>
    <citation>Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381-94. Review.</citation>
    <PMID>12696985</PMID>
  </reference>
  <reference>
    <citation>Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 Nov;34(11):1774-8. Epub 2006 May 30.</citation>
    <PMID>16735582</PMID>
  </reference>
  <reference>
    <citation>Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010 Feb;38(2):255-62. doi: 10.1177/0363546509355445.</citation>
    <PMID>20448192</PMID>
  </reference>
  <reference>
    <citation>Borzini P, Mazzucco L. Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion. 2005 Nov;45(11):1759-67. Review.</citation>
    <PMID>16271101</PMID>
  </reference>
  <reference>
    <citation>de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch GJ. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008 Jun;36(6):1171-8. doi: 10.1177/0363546508314430. Epub 2008 Mar 7.</citation>
    <PMID>18326832</PMID>
  </reference>
  <reference>
    <citation>Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009 Nov;37(11):2259-72. doi: 10.1177/0363546509349921. Review.</citation>
    <PMID>19875361</PMID>
  </reference>
  <reference>
    <citation>Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, Arciero RA, Beitzel K. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012 Feb 15;94(4):308-16. doi: 10.2106/JBJS.K.00430.</citation>
    <PMID>22336969</PMID>
  </reference>
  <reference>
    <citation>Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, Ramsey ML, Karli DC, Rettig AC. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014 Feb;42(2):463-71. doi: 10.1177/0363546513494359. Epub 2013 Jul 3.</citation>
    <PMID>23825183</PMID>
  </reference>
  <reference>
    <citation>Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011 Sep;45(12):966-71. doi: 10.1136/bjsm.2010.082503. Epub 2011 Mar 15.</citation>
    <PMID>21406450</PMID>
  </reference>
  <reference>
    <citation>Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011 Oct;39(10):2130-4. doi: 10.1177/0363546511417113. Epub 2011 Aug 2.</citation>
    <PMID>21813443</PMID>
  </reference>
  <reference>
    <citation>Raeissadat SA, Sedighipour L, Rayegani SM, Bahrami MH, Bayat M, Rahimi R. Effect of Platelet-Rich Plasma (PRP) versus Autologous Whole Blood on Pain and Function Improvement in Tennis Elbow: A Randomized Clinical Trial. Pain Res Treat. 2014;2014:191525. doi: 10.1155/2014/191525. Epub 2014 Jan 20.</citation>
    <PMID>24579044</PMID>
  </reference>
  <reference>
    <citation>Giusti I, Rughetti A, D'Ascenzo S, Millimaggi D, Pavan A, Dell'Orso L, Dolo V. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009 Apr;49(4):771-8. doi: 10.1111/j.1537-2995.2008.02033.x. Epub 2008 Dec 23.</citation>
    <PMID>19170984</PMID>
  </reference>
  <reference>
    <citation>de Vos RJ, Windt J, Weir A. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014 Jun;48(12):952-6. doi: 10.1136/bjsports-2013-093281. Epub 2014 Feb 21. Review.</citation>
    <PMID>24563387</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>February 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2015</study_first_posted>
  <last_update_submitted>February 26, 2015</last_update_submitted>
  <last_update_submitted_qc>February 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recent lateral humeral epicondylitis</keyword>
  <keyword>platelet-rich plasma</keyword>
  <keyword>infiltration</keyword>
  <keyword>tennis elbow</keyword>
  <keyword>ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

